Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis

In conclusion, this study recognized linc00460 as a new oncogenic lncRNA in OS and suggests that the linc00460/miR-1224-5p/FADS1 axis might be a potential therapeutic target for OS.
Source: Life Sciences - Category: Biology Source Type: research